Johnson & Johnson (JNJ) Shares are Down -0.73%

Johnson & Johnson (JNJ) : During the past 4 weeks, traders have been relatively bearish on Johnson & Johnson (JNJ), hence the stock is down -4.74% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.08% relative to the S&P 500. The 4-week change in the price of the stock is -4.94% and the stock has fallen -0.73% in the past 1 week.

For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 2.15% and the fifty day Moving Average is 1.59%. Johnson & Johnson is up 5.99% in the last three month period. Year-to-Date the stock performance stands at 18.35%.

Johnson & Johnson (JNJ) : 13 Wall Street analysts covering Johnson & Johnson (JNJ) believe that the average level the stock could reach for the short term is $125. The maximum price target given is $142 and the minimum target for short term is around $93, hence the standard deviation is calculated at $14.48.


Johnson & Johnson (NYSE:JNJ): stock turned positive on Friday. Though the stock opened at $118.84, the bulls momentum made the stock top out at $119.74 level for the day. The stock recorded a low of $118.56 and closed the trading day at $119.04, in the green by 0.40%. The total traded volume for the day was 6,482,673. The stock had closed at $118.57 in the previous days trading.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.